company-logo

Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. The company offers XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of uveitis macular edema. It also develops CLS-AX, an axitinib injectable suspension for suprachoroidal injection, which is in Phase 1/2a clinical trial; and CLS-301, an integrin inhibitor suspension for the treatment of diabetic macular edema and macular degeneration. The company has a collaboration with Bausch Health, Arctic Vision, REGENXBIO, Inc., and Aura Biosciences. Clearside Biomedical, Inc. was incorporated in 2011 and is headquartered in Alpharetta, Georgia.

Clearside Biomedical Dividend Announcement

Clearside Biomedical does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
Stay tuned for updates on Clearside Biomedical dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Clearside Biomedical Dividend History

Clearside Biomedical Dividend Yield

Clearside Biomedical current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Clearside Biomedical stock? Use our calculator to estimate your expected dividend yield:

Clearside Biomedical Financial Ratios

P/E ratio-2.43
PEG ratio0.59
P/B ratio-2.88
ROE169.71%
Payout ratio0.00%
Current ratio5.07
Quick ratio5.07
Cash Ratio3.10

Clearside Biomedical Dividend FAQ

Does Clearside Biomedical stock pay dividends?
Clearside Biomedical does not currently pay dividends to its shareholders.
Has Clearside Biomedical ever paid a dividend?
No, Clearside Biomedical has no a history of paying dividends to its shareholders. Clearside Biomedical is not known for its dividend payments.
Why doesn't Clearside Biomedical pay dividends?
There are several potential reasons why Clearside Biomedical would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Clearside Biomedical ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Clearside Biomedical has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Clearside Biomedical a dividend aristocrat?
Clearside Biomedical is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Clearside Biomedical a dividend king?
Clearside Biomedical is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Clearside Biomedical a dividend stock?
No, Clearside Biomedical is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Clearside Biomedical stocks?
To buy Clearside Biomedical you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Clearside Biomedical stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.